Randomised phase 3 open-label trial of first-line treatment with gemcitabine in association with docetaxel or paclitaxel in women with metastatic breast cancer: a comparison of different schedules and treatments / Del Mastro, L; Fabi, A; Mansutti, M; DE LAURENTIIS, Michelino; Durando, A; Merlo, Df; Bruzzi, P; La Torre, I; Ceccarelli, M; Kazeem, G; Marchi, P; Boy, D; Venturini, M; DE PLACIDO, Sabino; Cognetti, F.. - In: BMC CANCER. - ISSN 1471-2407. - ELETTRONICO. - 13:(2013), p. 164. [10.1186/1471-2407-13-164]
Randomised phase 3 open-label trial of first-line treatment with gemcitabine in association with docetaxel or paclitaxel in women with metastatic breast cancer: a comparison of different schedules and treatments.
DE LAURENTIIS, MICHELINO;DE PLACIDO, SABINO;
2013
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
